Use of hospice at end of life is significantly influenced by physician characteristics

the ONA take:

The strongest known predictor of whether a patient will enroll in hospice care is the individual physician the patient sees, according to new research from Brigham and Women’s Hospital.

This factor outweighs other known factors, including geographic location, patient age, race, and comorbidities.

After controlling for other factors that predict hospice enrollment, the researchers found that patients were 27% more likely to enroll in hospice if they saw a physician in the top 10% of hospice use, compared with those who saw a physician in the bottom 10%. In addition, they found that a large number of cancer patients were seen by a relatively small group of physicians.

Study results also showed that regional factors, greater comorbidity, and physician specialty were significantly associated with the likelihood of hospice enrollment.

A new effect seen in this study was physicians associated with for profit hospitals were less likely to have patients enroll in hospice, compared with physicians with non-profit hospitals.

Use of hospice at end of life is significantly influenced by physician characteristics
The strongest known predictor of whether a patient will enroll in hospice care is the individual physician the patient sees.
New research from Brigham and Women's Hospital finds that physician characteristics are the strongest predictor of whether a patient will be referred to hospice care.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs